Opal S M, Palardy J E, Marra M N, Fisher C J, McKelligon B M, Scott R W
Infectious Disease Division, Memorial Hospital, Providence, Rhode Island.
Lancet. 1994 Aug 13;344(8920):429-31. doi: 10.1016/s0140-6736(94)91767-1.
Endotoxin initiates the systemic inflammatory response, haemodynamic changes, and multi-organ failure that may occur as a consequence of systemic gram-negative bacterial infection. The serum protein lipopolysaccharide-binding protein (LBP) binds to the lipid A component of bacterial endotoxin and facilitates its delivery to the CD14 antigen on the macrophage, where inflammatory cytokines are released and a cascade of host mediators is initiated. The neutrophil granular protein bactericidal/permeability-increasing protein (BPI) competes with LBP for endotoxin binding and functions as a molecular antagonist of LBP-endotoxin interactions. We have measured concentrations of both proteins in body fluids from 49 consecutive patients. In 16 of 17 samples of fluid from closed-space infections, BPI was present in greater concentration than LBP (median BPI/LBP ratio 7.6 [95% CI 2.32-22.1]). The ratio of BPI and LBP was not significantly different from 1.0 in abdominal fluid from 10 patients with peritonitis (ratio 0.235 [0.18-0.47]), whereas the BPI/LBP ratio was low in 22 non-infected body fluids (0.01 [0.001-0.04]) and concentrations of both proteins approached those in normal human plasma. BPI concentrations were directly correlated with the quantity of neutrophils within clinical samples (rs = 0.81, p < 0.0001). Thus, within abscess cavities BPI is available in sufficient quantities for effective competition with LBP for endotoxin. BPI may attenuate the local inflammatory response and the systemic toxicity of endotoxin release during gram-negative infections.
内毒素可引发全身炎症反应、血流动力学变化以及多器官功能衰竭,这些情况可能是全身性革兰氏阴性菌感染的后果。血清蛋白脂多糖结合蛋白(LBP)与细菌内毒素的脂质A成分结合,并促进其传递至巨噬细胞上的CD14抗原,在那里会释放炎性细胞因子并启动一系列宿主介质。中性粒细胞颗粒蛋白杀菌/通透性增加蛋白(BPI)与LBP竞争内毒素结合,并作为LBP - 内毒素相互作用的分子拮抗剂发挥作用。我们测量了49例连续患者体液中这两种蛋白的浓度。在17份来自密闭空间感染的体液样本中的16份中,BPI的浓度高于LBP(BPI/LBP比值中位数为7.6 [95%可信区间2.32 - 22.1])。10例腹膜炎患者腹腔液中BPI和LBP的比值与1.0无显著差异(比值为0.235 [0.18 - 0.47]),而在22份未感染的体液中BPI/LBP比值较低(0.01 [0.001 - 0.04]),且两种蛋白的浓度接近正常人血浆中的浓度。BPI浓度与临床样本中的中性粒细胞数量直接相关(rs = 0.81,p < 0.0001)。因此,在脓肿腔内,BPI有足够的量与LBP有效竞争内毒素。BPI可能会减轻革兰氏阴性菌感染期间局部炎症反应和内毒素释放的全身毒性。